Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The impact of sentinel lymph node biopsy and magnetic resonance imaging on important outcomes among patients with ductal carcinoma in situ.

Tuttle TM, Shamliyan T, Virnig BA, Kane RL.

J Natl Cancer Inst Monogr. 2010;2010(41):117-20. doi: 10.1093/jncimonographs/lgq023. Review.

2.

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.

van Roozendaal LM, Goorts B, Klinkert M, Keymeulen KBMI, De Vries B, Strobbe LJA, Wauters CAP, van Riet YE, Degreef E, Rutgers EJT, Wesseling J, Smidt ML.

Breast Cancer Res Treat. 2016 Apr;156(3):517-525. doi: 10.1007/s10549-016-3783-2. Epub 2016 Apr 15.

3.

[Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].

Ruvalcaba-Limón E, de Jesús Garduño-Raya M, Bautista-Piña V, Trejo-Martínez C, Maffuz-Aziz A, Rodríguez-Cuevas S.

Cir Cir. 2014 Mar-Apr;82(2):129-41. Spanish.

PMID:
25312311
4.

Ductal carcinoma in situ: value of sentinel lymph node biopsy.

Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.

J Surg Oncol. 2006 Oct 1;94(5):426-30. Review.

PMID:
16967457
5.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
6.

Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?

Murthy V, Chamberlain RS.

Clin Breast Cancer. 2013 Jun;13(3):180-7. doi: 10.1016/j.clbc.2012.12.001. Epub 2013 Jan 26.

PMID:
23357305
7.
8.

Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Shapiro-Wright HM, Julian TB.

J Natl Cancer Inst Monogr. 2010;2010(41):145-9. doi: 10.1093/jncimonographs/lgq026. Review.

9.

Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.

Usmani S, Khan HA, Al Saleh N, abu Huda F, Marafi F, Amanguno HG, Al Nafisi N, Al Kandari F.

Nucl Med Commun. 2011 Nov;32(11):1084-7. doi: 10.1097/MNM.0b013e328349eafc.

PMID:
21862942
10.

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.

Breast Cancer. 2000 Jan;7(1):87-94.

PMID:
11029778
11.

[Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].

Sampol C, Giménez M, Torrecabota J, Serra C, Canet R, Daumal J, Peña C, Gonzalez L, Hernandez E, Graner A, Pozo A, Vega F.

Rev Esp Med Nucl. 2010 Sep-Oct;29(5):241-5. doi: 10.1016/j.remn.2010.02.007. Epub 2010 May 13. Spanish.

12.

Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.

Kaur P, Kiluk JV, Meade T, Ramos D, Koeppel W, Jara J, King J, Cox CE.

Ann Surg Oncol. 2011 Mar;18(3):727-32. doi: 10.1245/s10434-010-1120-2. Epub 2010 Jul 1.

PMID:
20593244
13.

Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.

Intra M, Trifirò G, Viale G, Rotmensz N, Gentilini OD, Soteldo J, Galimberti V, Veronesi P, Luini A, Paganelli G, Veronesi U.

Ann Surg Oncol. 2005 Nov;12(11):895-9. Epub 2005 Sep 29.

PMID:
16195833
14.

Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast.

D'Eredità G, Giardina C, Napoli A, Ingravallo G, Troilo VL, Fischetti F, Berardi T.

Tumori. 2009 Nov-Dec;95(6):706-11.

15.

Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion.

Zavagno G, Belardinelli V, Marconato R, Carcoforo P, Franchini Z, Scalco G, Burelli P, Pietrarota P, Mencarelli R, Marconato G, Nitti D.

Breast. 2007 Apr;16(2):146-51. Epub 2006 Oct 12.

PMID:
17046258
16.

Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer.

van Roozendaal LM, Schipper RJ, Smit LH, Brans BT, Beets-Tan RG, Lobbes MB, Boersma LJ, Smidt ML.

Ann Surg Oncol. 2015 Nov;22(12):3824-30. doi: 10.1245/s10434-015-4413-7. Epub 2015 Feb 24.

17.

[The role of sentinel lymph node biopsy in breast cancer non-invading-duct].

Török K, Péley G, Mátrai Z, Bidlek M, Szabó E, Sinkovics I, Polgár C, Farkas E, Orosz Z, Köves I.

Magy Seb. 2006 Jun;59(3):173-8. Hungarian.

PMID:
16937792
18.

Risk factor for axillary lymph node metastases in microinvasive breast cancer.

Ko BS, Lim WS, Kim HJ, Yu JH, Lee JW, Kwan SB, Lee YM, Son BH, Gong GY, Ahn SH.

Ann Surg Oncol. 2012 Jan;19(1):212-6. doi: 10.1245/s10434-011-1812-2. Epub 2011 Jun 2.

PMID:
21633867
19.

Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.

Mokhtar M, Tadokoro Y, Nakagawa M, Morimoto M, Takechi H, Kondo K, Tangoku A.

Breast Cancer. 2016 Mar;23(2):202-10. doi: 10.1007/s12282-014-0551-1. Epub 2014 Jul 29.

PMID:
25069434
20.

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Virnig BA, Tuttle TM, Shamliyan T, Kane RL.

J Natl Cancer Inst. 2010 Feb 3;102(3):170-8. doi: 10.1093/jnci/djp482. Epub 2010 Jan 13. Review.

PMID:
20071685

Supplemental Content

Support Center